Close Menu

NEW YORK – Genetic Signatures said Wednesday it has received the CE mark for its severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) detection kit, enabling the kit to be marketed in the European Union and other countries that recognize the designation.

Using samples collected from nose or throat swabs, the kit can run on Genetic Signatures' highest throughput instrument, the GS-1000, which can process about 1,500 samples in a 24-hour period, in a fully staffed laboratory and in batches of 188 samples per run, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An Associated Press report says China refrained from releasing the SARS-CoV-2 genome for more than a week in January, frustrating the World Health Organization.

The Lancet and the New England Journal of Medicine have issued expressions of concern regarding the data used in two COVID-19 papers, the New York Times reports. 

Researchers have sequenced the genome of the mayfly, garnering insight into how insects evolved wings, Science reports.

In Genome Research this week: gene expression in primate brain regions, inversions and breakpoint inverted repeats in the human genome, and more.